Major Milestone Achieved in NORSE EIGHT Clinical Trial Investigating ONS5010 as a Potential Treatment for Neovascular AgeRelated Macular Degeneration
As of January 31, 2024, a major milestone has been achieved in the NORSE EIGHT clinical trial. The trial is ...
